Treatment with Sildenafil Promotes Angiogenesis and Modulates Immune Response in Ischemic Muscle Tissue

Area of Science:

• Vascular Biology
• Regenerative Medicine
• Pharmacology

Background:

• Sildenafil (phosphodiesterase-5 inhibitor) is known to support vascular remodeling.
• Its specific effects on angiogenesis and regeneration in ischemic muscle tissue require further investigation.

Purpose of the Study:

• To investigate the role of sildenafil in promoting angiogenesis and regeneration of ischemic muscle tissue.
• To analyze the impact of sildenafil on cellular apoptosis, capillary formation, and inflammatory cell infiltration in a murine hindlimb ischemia model.

Main Methods:

• A murine hindlimb ischemia model was established using femoral artery ligation (FAL).
• Mice were treated with sildenafil or a control, and gastrocnemius muscles were analyzed via histology and immunofluorescence.
• Key markers assessed included apoptosis (TUNEL), capillary density (CD31), proliferation (BrdU), leukocytes (CD45), and macrophage polarization (CD68, MRC1).

Main Results:

• Sildenafil treatment significantly reduced apoptotic areas in ischemic tissue.
• Increased angiogenesis was observed, indicated by a higher capillary-to-muscle fiber ratio and more proliferating capillary cells.
• Sildenafil decreased leukocyte and macrophage infiltration, shifting macrophages towards a pro-angiogenic M2-like phenotype.

Conclusions:

• Sildenafil treatment promotes angiogenesis and regeneration of ischemic muscle tissue.
• The mechanism likely involves attenuation of inflammatory responses and promotion of M2-like macrophage polarization.
• These findings suggest sildenafil's therapeutic potential for ischemic conditions affecting muscle tissue.